Clinical Trial Update: Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avelumab (avelumab)
• Cetuximab (cetuximab)

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Metastatic Colorectal Cancer, RAS Wild Type | Phase 2 | Status: COMPLETED